Novel peptide-based therapeutics for reprogramming the tumour stroma extracellular matrix using molecular modelling and computational engineering

Project Information

ACT-MATRIX

Grant agreement ID: 101188310

DOI

10.3030/101188310

EC signature date 13 December 2024

Start date 1 January 2025

End date 31 December 2026

Funded under

• The European Innovation Council (EIC)

Total cost

No data

EU contribution

€ 2 434 790,33

Coordinated by

APMONIA THERAPEUTICS
France

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Thrombospondin-1–CD47 signaling contributes to the development of T cell exhaustion in cancer

Author(s): Chien-Huan Weng, Anais Assouvie, Lauren Dong, Jean-Christophe Beltra, Sadna Budhu, Levi Mangarin, Yacine Marouf, Lucia Morgado-Palacin, Cailian Liu, Sébastien Monette, Jonathan F. Khan, Isabell Schulze, Dmitriy Zamarin, Linda Hamadene, Fadi Samaan, Daniel Hirschhorn, Stephane Pourpe, David Schröder, Roberta Zappasodi, Pamela M. Holland, Niroshana Anandasabapathy, E. John Wherry, Jedd D. Wolchok, Taha Merghoub
Published in: Nature Immunology, Issue 26, 2025, ISSN 1529-2908
Publisher: Springer Science and Business Media LLC
DOI: 10.1038/S41590-025-02321-5

Conference proceedings (2)

ASMB 2025 Biennial Meeting Abstracts, November 16-19, 2025, Baltimore, MD

Published in: Journal of Histochemistry & Cytochemistry, Issue 73, 2025, ISSN 0022-1554
Publisher: SAGE Publications
DOI: 10.1369/00221554251387990

Abstracts

Published in: Molecular Oncology, Issue 19, 2025, ISSN 1574-7891
Publisher: Wiley
DOI: 10.1002/1878-0261.70070